Nexalin Technology Inc (NXL) saw an uptrend of 12.40% in the recent trading with $1.45 being its most recent. The current price level -67.71% lower than the highest price of $4.49 marked by the stock while trading over the past 52-weeks, whereas it is 106.55% higher than the lowest price of $0.70 the company dropped to over past 52-weeks. The latest news story on NXL appeared in (GlobeNewswire) under the title “Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer’s and Traumatic Brain Injury Programs”.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
Nexalin Technology Inc Earnings – What Happened With NXL
Coming around sales and income figures on NXL Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Nexalin Technology Inc (NXL) last released financial results for the quarter that ended 9/30/2024, posting a surprise factor of -91.67% for net revenue.
NXL – Nexalin Technology Inc Stock Earnings Estimates
The perspective of Nexalin Technology Inc (NASDAQ:NXL)’s current quarter earnings identifies that analysts are in consensus over the estimate of -0.12 for stock’s EPS in the current quarter. Nexalin Technology Inc (NXL) last released financial results for the quarter that ended 9/30/2024, posting a surprise factor of -91.67% for net revenue. Company’s EPS for the last quarter was -0.23.
Nexalin Technology Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 17.42 million. NXL does have institutional investors; and they hold 7.36% of the stock.
As on 2024-06-30, MORGAN STANLEY was the top most holder in Nexalin Technology Inc (NASDAQ:NXL) with an ownership of 59805.0 shares of the company or 0.7977 of the stake worth $0.1 million. The filing also reveals CVI HOLDINGS, LLC as the second largest holder in the company with a control over 0.7397 of the outstanding shares. Its stake is worth $93731.0 for having 55462.0 shares in hand.
GEODE CAPITAL MANAGEMENT, LLC also came holding a key position in the company during the recent quarter and it now holds 0.5877 of the outstanding shares. With this there are now 20.0 institutions which have possession in NXL’s shares.
Key Metrics for NXL
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Nexalin Technology Inc has a debt to equity ratio of 0.00.
